Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Coltene Holding AGXSWX:CLTN -1.99%66 Cash-to-Debt is No Debt (1) as of Jun. 2026, which is 100% below its 10-year median of 5,001.33. GuruFocus rates XSWX:CLTN with a GF Score™ of 66/100 and a GF Value™ of CHF51.29 (Fairly Valued). The stock has 4 warning signs investors should review. Among 840 Medical Devices & Instruments companies, Coltene Holding AG ranks worse than 68.45% on this metric.
Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Coltene Holding AG's cash to debt ratio for the quarter that ended in Jun. 2026 was No Debt (1).
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Coltene Holding AGcould pay off its debt using the cash in hand for the quarter that ended in Jun. 2026.
(1) Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
The historical rank and industry rank for Coltene Holding AG's Cash-to-Debt or its related term are showing as below:
XSWX:CLTN'
s Cash-to-Debt Range Over the Past 10 Years
Min: 0.38 Med: 5001.33 Max: No Debt
Current: 0.57
During the past 13 years, Coltene Holding AG's highest Cash to Debt Ratio was No Debt. The lowest was 0.38. And the median was 5001.33.
XSWX:CLTN's Cash-to-Debt is ranked worse than 68.45% of 840
companies
in the Medical Devices & Instruments industry
Industry Median: 1.635
vs XSWX:CLTN: 0.57
Coltene Holding AG (XSWX:CLTN) Cash-to-Debt Explanation
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.
Coltene Holding AG Cash-to-Debt Related Terms
Coltene Holding AG Cash-to-Debt Historical Data
* Premium members only.
The historical data trend for Coltene Holding AG's Cash-to-Debt can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
XSWX:CLTN vs ISRG, BDX, RMD: Cash-to-Debt Comparison
For the Medical Instruments & Supplies subindustry, Coltene Holding AG's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Coltene Holding AG Cash-to-Debt vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Coltene Holding AG's Cash-to-Debt distribution charts can be found below:
* The bar in red indicates where Coltene Holding AG's Cash-to-Debt falls into.
Coltene Holding AG's Cash to Debt Ratio for the quarter that ended in Jun. 2026 is calculated as:
Coltene Holding AG had no debt (1).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Cash-to-Debt of No Debt <sup>(1)</sup> mean?
Coltene Holding AG (XSWX:CLTN) has a Cash-to-Debt of No Debt (1) as of Jun. 2026. This is 100% below median its historical median of 5,001.33. Over the past decade, Coltene Holding AG's Cash-to-Debt has ranged from 0.38 to 10,000.00. According to the industry distribution chart, Coltene Holding AG ranks #575 out of 840 companies in the Medical Devices & Instruments industry, placing it in the top 68.5%.
Is Coltene Holding AG's Cash-to-Debt too high?
Coltene Holding AG's current Cash-to-Debt of No Debt (1) is 100% below median its 10-year median of 5,001.33. Over the past 10 years, this metric has ranged from a low of 0.38 to a high of 10,000.00. Based on the distribution chart, Coltene Holding AG ranks #575 out of 840 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Coltene Holding AG has a GF Score™ of 66/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Coltene Holding AG's Cash-to-Debt compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Coltene Holding AG ranks #575 out of 840 companies for Cash-to-Debt. This places Coltene Holding AG in the lower half of its industry. The industry median Cash-to-Debt is 1.64. Historically, Coltene Holding AG's own Cash-to-Debt has ranged from 0.38 to 10,000.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash-to-Debt for a Medical Devices & Instruments company?
The median Cash-to-Debt among Medical Devices & Instruments companies is 1.64, based on 840 companies in the industry. Companies in the top quartile (top 25%) have a Cash-to-Debt significantly above this median, while those in the bottom quartile fall well below. However, Cash-to-Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash-to-Debt mean?
A high Cash-to-Debt can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median Cash-to-Debt is 1.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Coltene Holding AG's current Cash-to-Debt is No Debt (1), which is 100% below median its own 10-year median of 5,001.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Coltene Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Coltene Holding AG (XSWX:CLTN) is currently considered Fairly Valued. The stock's GF Value™ is CHF51.29, compared to a current price of CHF46.80 — trading 8.8% below its estimated fair value. The current Cash-to-Debt is No Debt (1), which is 100% below median its 10-year median of 5,001.33. Coltene Holding AG's overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash-to-Debt calculated?
Cash-to-Debt is calculated from a company's financial statements. For Coltene Holding AG (XSWX:CLTN), the current Cash-to-Debt is No Debt (1) as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Coltene Holding AG (XSWX:CLTN) Overvalued in 2026?
Based on GuruFocus' analysis, Coltene Holding AG stock appears to be undervalued.
The current stock price of CHF46.80 is trading 8.8% below its estimated GF Value™ of CHF51.29.
GuruFocus considers Coltene Holding AG to be Fairly Valued.
Key valuation signals for XSWX:CLTN:
Cash-to-Debt: No Debt (1) (100% below median its 10-year median of 5,001.33)
GF Value™: CHF51.29 vs. price of CHF46.80 (8.8% below fair value)
No single metric tells the full story. See the XSWX:CLTN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Coltene Holding AG is a manufacturer and distributor of consumables and small devices for dental practices, dental service organisations (DSOs), dental clinics and laboratories, as well as for non-dental niches (e.g., clinics for ophthalmology or podiatry). The Group develops, manufactures, and sells mainly via distribution channels a broad and comprehensive range of disposables, tools, and equipment for dentists and dental laboratories. Geographically, it operates in EMEA, North America, Latin America, and Asia/Oceania, with maximum from North America.
66GF Score
Get the complete analysis for XSWX:CLTN
Cash-to-Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:CLTN has been successfully added to your 
